Recombinant Human proBNP

<strong>Recombinant Human proBNP</strong>_x000D_ <strong>Catalog number:</strong> B2016469_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 12036 Da_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80 °C_x000D_ <strong>Keywords:</strong> proBNP recombinant human_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357._x000D_ 2: Li F, Li H, Luo R, Pei JB, Yu XY. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation World J Clin Cases. 2023 Sep 16;11(26):6066-6072._x000D_ 3: Soleh MT, Foo JY, Bailey UM, Tan NY, Wan Y, Cooper-White J, Schulz BL, Punyadeera C. A rapid and cost-effective method of producing recombinant proBNP and NT-proBNP variants in Escherichia coli for immunoassay of heart failure Biotechnol Lett. 2014 Jan;36(1):133-40._x000D_ 4: Xu Y, Li Y, Bao W, Qiu S. Protective effects of recombinant human brain natriuretic peptide in perioperative period during open heart surgery Exp Ther Med. 2018 Mar;15(3):2869-2873._x000D_ 5: Li N, Gao X, Wang W, Wang P, Zhu B. Protective effects of recombinant human brain natriuretic peptide on the myocardial injury induced by acute carbon monoxide poisoning Cardiovasc Diagn Ther. 2020 Dec;10(6):1785-1794._x000D_ 6: Woodard GE, Rosado JA. Recent advances in natriuretic peptide research J Cell Mol Med. 2007 Nov-Dec;11(6):1263-71._x000D_ 7: Meng X, Fu M, Wang J, Xu H. Effects of Recombinant Human Brain Natriuretic Peptide in Patients with Acute Pulmonary Embolism Complicated with Right Ventricular Dysfunction Who Underwent Catheter-Directed Therapy Int Heart J. 2022;63(1):8-14._x000D_ 8: Dickey DM, Potter LR. ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency Clin Chem. 2011 Sep;57(9):1272-8._x000D_ 9: Miao ZL, Hou AJ, Zang HY, Huang RG, Zheng XQ, Lin HL, Wang W, Hou P, Xia F, Li ZQ. Effects of recombinant human brain natriuretic peptide on the prognosis of patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention: a prospective, multi-center, randomized clinical trial J Thorac Dis. 2017 Jan;9(1):54-63._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29075957">10: Abuzaanona A, Lanfear D. Pharmacogenomics of the Natriuretic Peptide System in Heart Failure Curr Heart Fail Rep. 2017 Dec;14(6):536-542. </a>_x000D_ _x000D_ <strong>Products Related to Recombinant Human proBNP can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>